End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)

University of Cincinnati

Status

Completed

Conditions

End Stage Liver Disease

Treatments

Device: bodystat quadscan 400

Device: Bodystat Quadscan 4000

Study type

Interventional

Funder types

Other

Identifiers

NCT00374582

BIA

Details and patient eligibility

About

The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)

Full description

The aim of this study is to report the validity of mBIA to determine body composition changes pre and post LVP (Large Volume Paracentesis)

18 years of age or older
Cirrhotic patients with refractory ascites requiring LVP (a treatment to remove large volumes of excess fluid from the abdominal cavity)
End Stage Liver Disease

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with ESLD requiring LVP.
Age over 18.
Ability to provide written informed consent.

Exclusion criteria

Organ retransplant candidates.
Patient with use of any investigational agent within 30 days before LVP.
Pregnant or lactating.
Patients with non-bioprosthetic heart valves pacemakers, defibrillators, artificial joints, pins, plates, or other types of metal objects in the body.
Amputations other than fingers or toes.